Talkspace, Inc. Q2 FY2025 earnings call

• Product and market expansion: Broadened reach with new Blues plans adding 16 million covered lives; saw growth in Medicare and military segments; in DTE, education - related new partnerships with universities and states expected to grow in Q3/Q4; established new partnerships with Amazon and Tia Health.
• AI - related innovations: Launched Taalcast to increase session completion rates; rolled out AI - powered smart evaluation to save provider time; developed safety and quality model for session analysis; improved suicide detection technology; working on behavioral health large language models to be available later this year.

Total revenue was $54.3 million, up 18% year - on - year. Payer revenue, the primary growth driver, was $40.5 million, up 35% year - on - year, with over 385,000 therapy sessions and over 111,000 unique payer members. DTE revenue was $9.4 million, down 2% year - on - year due to delayed new win closings. Consumer revenue was $4.4 million, down from $6.5 million a year ago as more Americans are covered via in - network benefits.

Full - year revenue guidance is $220 million to $235 million, and adjusted EBITDA is $14 million to $20 million. Payer business expected to grow over 30% annually. DTE business有望全年增长, with new deals closing in Q3/Q4 providing visibility. Marketing investments in first half, but operating leverage expected in second half with G&A savings.

• Market environment changes affecting marketing ROI. - Regulatory changes in AI use in mental health care, like Illinois' regulations. - Delayed new win closings in DTE affecting revenue recognition.

Q: Please give an update on Medicare?

A: Registrations continue to grow month - by - month, and we continue to explore different states. MAs are coming in, and we are refining marketing efforts around the populations.

Q: What about competition in the payer space?

A: The mental health TAM is large, and growth is fueled by the need for mental health services, so we are not seeing much impact from competitors.

Q: How do regulations on AI in mental health care affect the product?

A: Any AI therapy assistant needs clinical oversight by licensed clinicians and to exist in a HIPAA environment. Our products are being developed with these in mind.

Q: Can you talk about the cadence of revenues between Q3 and Q4?

A: Consistently ramping growth throughout the year, with Q3 benefiting from delayed deals in Q2 and Q4 expected to be at the highest run rate in 2025.

Q: Any details on employers and DTE?

A: For public entities like schools, sales cycles are longer. On the employer side, retention is better, but new sales channels are being employed with lower impact on the overall book of business.